28290-41-7

Basic information

• Product Name: TRANS,TRANS-FARNESYL BROMIDE
• Synonyms: FARNESYL BROMIDE;TRANS,TRANS-1-BROMO-3,7,11-TRIMETHYL-2,6,10-DODECATRIENE;TRANS,TRANS-FARNESYL BROMIDE;1-Bromo-3,7,11-trimethyl-2,6,10-dodecatriene;3,7,11-Trimethyl-2,6,10-dodecatrienyl bromide;(E,E)-Farnesyl Bromide;(2E,6E)-;trans,trans-Farnesyl bromide 95%
• CAS NO: 28290-41-7
• Molecular Formula: C₁₅H₂₅Br
• Molecular Weight: 285.26
• Product Categories: Mixed Fatty Acids;Fatty Acid Derivatives & Lipids;Glycerols;Aliphatics
• Mol File: 28290-41-7.mol
• Article Data: 87

Chemical Properties

• Boiling Point: 100-110 °C15 mm Hg(lit.)
• Flash Point: >230 °F
• Appearance: /
• Density: 1.052 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.000267mmHg at 25°C
• Refractive Index: n20/D 1.509(lit.)
• Storage Temp.: Hygroscopic, -20°C Freezer, Under Inert Atmosphere
• Solubility: Chloroform (Slightly), Ethyl Acetate (Slightly)
• CAS DataBase Reference: TRANS,TRANS-FARNESYL BROMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: TRANS,TRANS-FARNESYL BROMIDE(28290-41-7)
• EPA Substance Registry System: TRANS,TRANS-FARNESYL BROMIDE(28290-41-7)

Safety Data

• Hazard Codes: Xi
• Statements: 37/38-41
• Safety Statements: 26-39
• RIDADR: UN 3334
• WGK Germany: 3
• Hazardous Substances Data: 28290-41-7(Hazardous Substances Data)

Usage

Description

TRANS,TRANS-FARNESYL BROMIDE, also known as Farnesyl bromide, is an organic compound that serves as an analog of Farnesol. It is produced in the dimorphic fungus Candida albicans and is characterized by its brown oil appearance. TRANS,TRANS-FARNESYL BROMIDE is known for its chemical properties and versatile applications across various industries.

Uses

Used in Pharmaceutical Industry:
TRANS,TRANS-FARNESYL BROMIDE is used as a starting reagent for the synthesis of various compounds, such as S-trans, trans-farnesyl-L-cysteine methylester, umbelliprenin, (±)-farnesiferol A, and (±)-farnesiferol C. These synthesized compounds have potential applications in the development of new drugs and therapeutic agents.
Used in Chemical Synthesis:
TRANS,TRANS-FARNESYL BROMIDE is used as a key intermediate in the synthesis of prenylated peptides. These peptides are important in various biological processes and have potential applications in the development of novel pharmaceuticals and bioactive compounds.
Used in Research and Development:
Due to its unique chemical properties, TRANS,TRANS-FARNESYL BROMIDE is utilized in research and development for the study of various chemical reactions and the development of new synthetic methods. TRANS,TRANS-FARNESYL BROMIDE can be used to explore new pathways and create innovative products in the field of organic chemistry.

InChI:InChI=1/C15H25Br/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16/h7,9,11H,5-6,8,10,12H2,1-4H3/b14-9+,15-11+

Upstream product

• 7212-44-4 (+/-)-nerolidol 
• 1119-38-6 (S)-(+)-nerolidol 
• 4602-84-0 farnesol 
• 110-86-1 pyridine 
• 7789-60-8 phosphorus tribromide 
• 506-68-3 bromocyane 
• 108354-14-9 aurachin C 
• 106-28-5 Farnesol 
• 40716-66-3 (E)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol 
• 19954-66-6 ethyl farnesoate 
• 25996-10-5 (Z)-neryl bromide 
• 71668-79-6 2(E),8(E)-Farnesyl mesylate 
• 37905-04-7 (2E,6E)-8-bromo-3,7-dimethylocta-2,6-dienyl acetate 
• 37905-03-6 8-hydroxygeranyl acetate 

Downstream Products

• 19317-11-4 farnesal 
• 502-67-0 Farnesal 
• 762-29-8 6,10,14-trimethyl-5,9,13-pentadecatrien-2-one 
• 111-02-4 squalene 
• 111-02-4 2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene 
• 66958-75-6 1,4-Bis-benzyloxy-2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-28-(toluene-4-sulfonyl)-tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methyl-benzene 
• 56881-53-9 (E,E)-farnesyl phenylsulfone 
• 56881-54-0 2Z,6E-Farnesyl-phenyl-sulfon 
• 13832-82-1 <(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienyl>triphenylphosphoniumbromid 
• 16725-59-0 Diethyl-farnesylphenylmalonat 
• 23838-17-7 umbelliprenine 
• 113801-51-7 1-Benzenesulfonyl-2-((2E,6E)-3,7,11-trimethyl-dodeca-2,6,10-trienyl)-1H-indole 
• 103670-05-9 DL-2-Phenylglycin-farnesylester-hydrochlorid 
• 94286-83-6 6-farnesyl-1,5-dimethoxy-3-methyl-1,4-cyclohexadiene 

Relevant articles and documents

Protein degradation targeting chimeric compound, preparation method and medical application thereof

The invention relates to a protein degradation targeting chimeric compound, a preparation method and medical application thereof, specifically to a compound as shown in a general formula (I), a preparation method of the compound, and application of the co

Regiospecific Synthesis of Calcium-Independent Daptomycin Antibiotics using a Chemoenzymatic Method

Daptomycin (DAP) is a calcium (Ca2+)-dependent FDA-approved antibiotic drug for the treatment of Gram-positive infections. It possesses a complex pharmacophore hampering derivatization and/or synthesis of analogues. To mimic the Ca2+-binding effect, we used a chemoenzymatic approach to modify the tryptophan (Trp) residue of DAP and synthesize kinetically characterized and structurally elucidated regiospecific Trp-modified DAP analogues. We demonstrated that the modified DAPs are several times more active than the parent molecule against antibiotic-susceptible and antibiotic-resistant Gram-positive bacteria. Strikingly, and in contrast to the parent molecule, the DAP derivatives do not rely on calcium or any additional elements for activity.

ANTIBIOTIC COMPOUNDS

Provided herein are lipidated glycopeptide compounds of formula (I); or a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug thereof. R1 is a lipid, R2 is -H or a lipid, and R3 and R4 are as defined herein. These compounds have antibiotic activity. Also provided are formulations comprising such compounds; as well as such compounds or formulations for use as a medicament. The compounds and formulations may also be used in the treatment of bacterial infection.